FERRARI, CAMILLA
 Distribuzione geografica
Continente #
NA - Nord America 3.593
EU - Europa 2.342
AS - Asia 1.070
OC - Oceania 43
SA - Sud America 38
AF - Africa 7
Totale 7.093
Nazione #
US - Stati Uniti d'America 3.583
RU - Federazione Russa 1.147
HK - Hong Kong 436
IT - Italia 281
IE - Irlanda 276
PL - Polonia 252
SG - Singapore 250
SE - Svezia 173
CN - Cina 158
IN - India 84
DE - Germania 70
ID - Indonesia 53
FI - Finlandia 52
JO - Giordania 48
AU - Australia 43
BR - Brasile 35
GB - Regno Unito 27
KR - Corea 11
NL - Olanda 10
UA - Ucraina 10
BE - Belgio 8
VN - Vietnam 8
CH - Svizzera 7
CA - Canada 6
ES - Italia 6
CI - Costa d'Avorio 5
JP - Giappone 5
CZ - Repubblica Ceca 3
FR - Francia 3
GR - Grecia 3
PK - Pakistan 3
AT - Austria 2
BD - Bangladesh 2
DK - Danimarca 2
EC - Ecuador 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
KZ - Kazakistan 2
MX - Messico 2
PT - Portogallo 2
TR - Turchia 2
AR - Argentina 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 7.093
Città #
Santa Clara 1.299
Ashburn 412
Hong Kong 376
Dublin 275
Warsaw 252
Fairfield 228
Chandler 217
Singapore 156
Woodbridge 122
Seattle 97
Houston 95
Cambridge 85
Altamura 81
Lawrence 79
Florence 67
Moscow 66
Wilmington 66
Mumbai 60
Ann Arbor 58
Jakarta 53
Princeton 46
Dearborn 43
Melbourne 43
Helsinki 42
Boston 36
Buffalo 34
Bremen 33
Shanghai 32
San Diego 25
New York 23
Pune 21
Beijing 20
Medford 18
Kent 16
West Jordan 16
Los Angeles 15
Rome 15
Boardman 12
Seoul 11
Ferrara 10
Brussels 8
Falkenstein 8
Guangzhou 7
Yubileyny 7
Dong Ket 6
Falls Church 6
Lambeth 6
Lappeenranta 6
Norwalk 6
Abidjan 5
Barcelona 5
Misano Adriatico 5
Prato 5
Romola 5
Toronto 5
Zhengzhou 5
Bolzano 4
Genoa 4
Hefei 4
Hillsboro 4
London 4
Milan 4
Nuremberg 4
Wenzhou 4
Zurich 4
Bern 3
Fiesole 3
Frankfurt am Main 3
Munich 3
Nanjing 3
Prague 3
Santa Maria A Monte 3
Siena 3
The Dalles 3
Turin 3
Wuhan 3
Afragola 2
Almaty 2
Arezzo 2
Athens 2
Campi Bisenzio 2
Catania 2
Chicago 2
Codogno 2
Copenhagen 2
Council Bluffs 2
Dallas 2
Esmeraldas 2
Jenera 2
Jinan 2
Kilburn 2
Kunming 2
Lanzhou 2
Lisbon 2
Livorno 2
Matelica 2
Menlo Park 2
Monza 2
Nakano 2
Nanchang 2
Totale 4.867
Nome #
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 307
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 267
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 241
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 153
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 146
Biomarkers study in atypical dementia: proof of a diagnostic work-up 135
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 133
Primary Progressive Aphasia: Natural History in an Italian Cohort 132
The Games for Older Adults Active Life (GOAL) project for people with mild cognitive impairment and vascular cognitive impairment: A study protocol for a randomized controlled trial 131
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 124
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 121
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 119
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 113
The diagnosis of dementias: a practical tool not to miss rare causes 113
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 112
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 112
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 104
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 103
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 102
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 102
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 99
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 97
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 96
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 96
The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family 95
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 94
Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration 93
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 84
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients 84
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 84
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 83
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 82
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 82
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 81
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 81
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 79
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 79
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 79
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 79
Cognitive functioning among patients with diabetic foot 78
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 78
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 78
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 76
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 76
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 74
Late-onset Huntington disease: An Italian cohort 74
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 73
Differential early subcortical involvement in genetic FTD within the GENFI cohort 73
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 70
Intermediate alleles of HTT: A new pathway in longevity 67
Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation 67
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 66
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 65
The complexity of Alzheimer's disease: an evolving puzzle 65
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 64
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 63
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports 63
The Huntington’s Disease Gene in an Italian Cohort of Patients with Bipolar Disorder 63
null 63
How can elderly apolipoprotein E ε4 carriers remain free from dementia? 61
Parkinson-ALS with a novel MAPT variant 59
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 59
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 59
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 57
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 57
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 55
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 53
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 52
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 52
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 51
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 49
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 48
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 47
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 47
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 46
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 43
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 43
Structural brain splitting is a hallmark of Granulin-related Frontotemporal Dementia 36
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 36
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 33
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 33
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 32
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 26
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 21
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 21
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 20
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 19
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 19
Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort 18
Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia 15
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia 14
Totale 7.194
Categoria #
all - tutte 27.630
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.630


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020136 0 0 0 0 0 0 0 0 60 28 38 10
2020/2021357 27 36 19 46 13 14 13 22 50 73 17 27
2021/2022315 6 7 17 12 4 24 1 42 13 20 66 103
2022/20231.161 102 233 73 93 66 205 165 56 125 6 23 14
2023/2024910 30 50 76 32 39 84 57 406 23 56 37 20
2024/20253.652 119 434 276 640 1.143 563 61 276 140 0 0 0
Totale 7.194